Association of clinical symptoms and cardiometabolic dysregulations in patients with schizophrenia spectrum disorders

Patients with schizophrenia spectrum disorders (SSD) have a shortened life expectancy related to cardiovascular diseases. We investigated the association of cognitive, positive, and negative symptoms with cardiometabolic dysregulations in SSD patients. Overall, 1,119 patients from the Genetic Risk a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European psychiatry Jg. 67; H. 1; S. e7
Hauptverfasser:	Zhao, Chenxu, Habtewold, Tesfa Dejenie, Naderi, Elnaz, Liemburg, Edith J., Bruggeman, Richard, Alizadeh, Behrooz Z.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Cambridge University Press 13.12.2023
Schlagworte:	Antipsychotics Biomarkers Blood pressure cardiometabolic biomarkers Cardiovascular Diseases Cholesterol cognition Cognitive ability Glucose Glycated Hemoglobin Health risk assessment High density lipoprotein Humans Lipoproteins Longitudinal studies Memory metabolic syndrome Metabolism Psychosis Psychotic Disorders - diagnosis psychotic symptoms Psychotropic drugs Risk Factors Schizophrenia Schizophrenia - complications Schizophrenia - drug therapy Triglycerides metabolic syndrome psychotic symptoms schizophrenia cardiometabolic biomarkers cognition
ISSN:	0924-9338, 1778-3585, 1778-3585
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!